2019-19779. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is publishing a Start Printed Page 48152list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Start SignatureTable 1—List of Information Collections Approved By OMB
Title of collection OMB control No. Date approval expires Disease Awareness and Prescription Drug Promotion on Television 0910-0874 8/31/2021 Reporting Associated with New Animal Drug Applications and Veterinary Master Files 0910-0032 7/31/2022 Substances Generally Recognized as Safe: Notification Procedure 0910-0342 7/31/2022 Establishing and Maintaining Lists of U.S. Product Manufacturers/Processors with Interest in Exporting CFSAN-Regulated Products 0910-0509 7/31/2022 Oversight of Clinical Investigations; A Risk-Based Approach to Monitoring 0910-0733 7/31/2022 Safety Labeling Changes; Implementation of the Federal Food, Drug, and Cosmetic Act 0910-0734 7/31/2022 Accreditation of Third Party Certification Bodies to Conduct Food Safety Audits and Issue Certifications 0910-0750 7/31/2022 Mitigation Strategies to Protect Food Against Intentional Adulteration 0910-0812 7/31/2022 Standards for the Growing, Harvesting, Packaging, and Holding of Produce for Human Consumption 0910-0816 7/31/2022 De Novo Classification Process (Evaluation of Automatic Class III Designation) 0910-0844 8/31/2022 Dated: September 6, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-19779 Filed 9-11-19; 8:45 am]
BILLING CODE 4164-01-P
Document Information
- Published:
- 09/12/2019
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2019-19779
- Pages:
- 48151-48152 (2 pages)
- Docket Numbers:
- Docket Nos. FDA-2018-N-3516, FDA 2019-N-0482, FDA-2012-N-0021, FDA-2018-N-4042, FDA-2011-D-0597, FDA-2018-N-4735, FDA-2019-N-0721, FDA-2013-N-1425, FDA-2018-D-3631, and FDA-2011-D-0689
- PDF File:
- 2019-19779.pdf
- Supporting Documents:
- » Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
- » Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Oversight of Clinical Investigations: A Risk-Based Approach to Monitoring
- » Agency Information Collection Activities; Proposed Collection; Comment Request; Oversight of Clinical Investigations: A Risk-Based Approach to Monitoring
- » Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
- » Agency Information Collection Activities; Submission for Office of Management and Budget Review; Guidance for Industry on Oversight of Clinical Investigations: A Risk-Based Approach to Monitoring
- » Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Oversight of Clinical Investigations: A Risk-Based Approach To Monitoring
- » Guidance for Industry on Oversight of Clinical Investigations--A Risk-Based Approach to Monitoring
- » Guidance for Industry on Oversight of Clinical Investigations--A Risk-Based Approach to Monitoring; Availability
- » Agency Information Collection Activities; Proposals, Submissions, and Approvals: Draft Guidance for Industry; Oversight of Clinical Investigations; A Risk-Based Approach to Monitoring
- » Draft Guidance for Industry; Oversight of Clinical Investigations; A Risk-Based Approach to Monitoring